Fidocare XL contains nifedipine, which belongs to a group of medicines called calcium antagonists. Fidocare XL is used to treat:
- high blood pressure or
- angina (chest pain)
Fidocare XL contains nifedipine, which belongs to a group of medicines called calcium antagonists. Fidocare XL is used to treat:
Do not take Fidocare XL:
Do not take Fidocare XL if any of the above applies to you. If you are not sure, talk to your doctor, nurse or pharmacist before you are given Fidocare XL.
Take special care with Fidocare XL:
Fidocare XL is not intended to be used in children and adolescents under the age of 18 years.
Always tell your healthcare provider if you are taking any other medicine. (This includes all complementary or traditional medicines.) Tell your doctor if you are taking:
Do not share medicines prescribed for you with any other person. Always take Fidocare XL exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
If you have the impression that the effect of Fidocare XL is too strong or too weak, talk to your doctor or pharmacist.
The tablets should be swallowed whole with a glass of water, either with or without food. The tablets should be taken at approximately 24-hour intervals, i.e. at the same time each day, preferably during the morning. Fidocare XL must be swallowed whole; under no circumstances should they be bitten, chewed or broken up. Do not take the tablets with grapefruit juice.
Fidocare XL is specially formulated so that you only have to take one dose each day.
Dose for high blood pressure: the usual dose is 1 tablet, once a day.
Dose for angina: the dose depends on your individual requirements. Your doctor will decide how much you should take.
Use in elderly: No dose adjustment in elderly people above 65 years is necessary.
Use in adults and the elderly with kidney problems: No dosage adjustment is required in patients with kidney problems.
Use in children and adolescents: Fidocare XL is not recommended for use in children and adolescents below 18 years of age, because there are only limited data on the safety and efficacy in this population.
Use in patients with liver problems: Fidocare XL should not be administered to patients with liver problems.
If you take more Fidocare XL than you should: In the event of overdosage, consult your doctor or pharmacist. If neither is available, contact the nearest hospital or poison centre. Taking too many tablets may cause your blood pressure to become too low and your heartbeat to speed up or slow down. It may also lead to an increase in your blood sugar level or an increase in the acidity of your blood, swelling in the lungs, low blood oxygen levels and disturbances in consciousness, possibly leading to unconsciousness.
If you forget to take Fidocare XL: Take your normal dose immediately and continue taking your tablets at the usual time of day, waiting at least 12 hours before taking the next dose. Do not take a double dose to make up for a forgotten individual dose. If you have any further questions on the use of this medicine, ask your doctor.
Fidocare XL can have side effects. Not all side effects reported for Fidocare XL are included in this leaflet. Should your general health worsen or if you experience any untoward effects while taking Fidocare XL, please consult your healthcare provider for advice.
If any of the following happens, stop receiving Fidocare XL and tell your doctor immediately or go to the casualty department at your nearest hospital:
These are all very serious side effects. If you have them, you may have had a serious reaction to Fidocare XL. You may need urgent medical attention or hospitalisation.
Tell your doctor if you notice any of the following:
If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.
If you get side effects, talk to your doctor or pharmacist. You can also report side effects to SAHPRA via the Med Safety APP (Medsafety X SAHPRA) and eReporting platform (who-umc.org) found on SAHPRA website. By reporting side effects, you can help provide more information on the safety of Fidocare XL.
The Fidocare XL Tablets professional information leaflet below is the property of Biotech Laboratories and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
The patient information text is available above. Load the original PDF only when you need it.